Mapping Dural and Periosteal SV2C, a Botulinum Toxin A Receptor, in the Mouse
We interpret these findings as suggesting that many of the labeled axons are peripheral nerve axons (peripherin-positive) of unmyelinated sensory and possibly parasympathetic origin (CGRP-positive), and that some of these sensory axons are nociceptors (NaV1.8-positive). Clinically, these findings demonstrate an abundance of axons containing onabotA receptors in the vicinity of scalp structures commonly injected with onabotA for the treatment of chronic migraine. Dense labeling in the periosteum provides another rationale for the possibility that onabotA injections in this layer of the scalp may be advantageous.
Authors
- Brett Dabruzzo (ORCID: https://orcid.org/0009-0008-3048-2633)
- Andrew M. Strassman (ORCID: https://orcid.org/0000-0002-0213-3048)
- Anisa Dehghani (ORCID: https://orcid.org/0000-0002-7117-4599)
- Ron S. Broide (ORCID: https://orcid.org/0000-0003-1747-0116)
- Agustin Melo‐Carrillo
- Mitchell F. Brin (ORCID: https://orcid.org/0000-0002-1989-6076)
- Aubrey Manack Adams
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of California, Irvine (US)
- Allergan (Ireland) (IE)
Publication Details
- Journal
- Toxins
- Published
- 2025-10-17
- DOI
- https://doi.org/10.3390/toxins17100509
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00